Updated Jul 16, 2026
Purdue David Ryan is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $1.22M.
David Ryan Purdue is an executive associated with AbbVie Inc., a global biopharmaceutical company. He has held various roles within the organization, contributing to its strategic initiatives and operational management. His experience in the pharmaceutical industry has positioned him as a notable figure within AbbVie.
| Role | Insider |
|---|---|
| Notability | 75/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-11 | ABBV | AbbVie Inc. | F — Tax withholding / forfeiture | 2.1K | $232.08 | $489K |
| 2026-03-06 | ABBV | AbbVie Inc. | S — Open-market sale | 5.2K | $233.56 | $1.22M |
| 2026-03-03 | ABBV | AbbVie Inc. | F — Tax withholding / forfeiture | 2.7K | $232.08 | $625K |
| 2026-02-20 | ABBV | AbbVie Inc. | A — Grant or award | 1.4K | $0.00 | |
| 2026-02-20 | ABBV | AbbVie Inc. | A — Grant or award | 1.3K | $0.00 | |
| 2026-02-20 | ABBV | AbbVie Inc. | A — Grant or award | 890 | $0.00 | |
| 2026-02-20 | ABBV | AbbVie Inc. | A — Grant or award | 2.5K | $0.00 |
David Ryan Purdue is an executive associated with AbbVie Inc., a global biopharmaceutical company. He has held various roles within the organization, contributing to its strategic initiatives and operational management. His experience in the pharmaceutical industry has positioned him as a notable figure within AbbVie.…
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($1.22M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Purdue David Ryan profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.